Quest for the right Drug

|
עמוד הבית / טוברסול / מידע מעלון לרופא

טוברסול TUBERSOL (TUBERCULIN PURIFIED PROTEIN)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תוך-עורי : INTRADERMAL

צורת מינון:

תמיסה להזרקה : SOLUTION FOR INJECTION

Special Warning : אזהרת שימוש

WARNINGS
Hypersensitivity

Allergic reactions may occur following the use of TUBERSOL even in persons with no prior history of hypersensitivity to the product components. Epinephrine injection (1:1,000) and other appropriate agents used for the control of immediate allergic reactions must be immediately available.
Syncope
Syncope (fainting) can occur in association with administration of injectable medicines, including TUBERSOL. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope.
PRECAUTIONS
General
Diagnostic Limitations
False positive or false negative tuberculin skin test reactions may occur in some individuals. (See Interpretation of the Test.)
False positive tuberculin reaction tests occur in individuals who have been infected with other mycobacteria, including vaccination with BCG.
Not all infected persons will have a delayed hypersensitivity reaction to a tuberculin test.
Many factors have been reported to cause a decreased ability to respond to the tuberculin test in the presence of tuberculous infection. (See Interpretation of the Test.) Information for Patients
Prior to administration of TUBERSOL, the patient’s current health status and medical history should be reviewed. The physician should review the patient’s immunization history for possible sensitivity to components of TUBERSOL.
The healthcare provider should inform the patient of the need to return for the reading of the test.
Self-reading of the test has been shown to be inaccurate and unreliable.
The healthcare provider should give the patient a permanent personal record. In addition, it is essential that the health professional record the testing history in the permanent medical record of each patient. This permanent office record should contain the name of the product, date given, dose, manufacturer, and lot number, as well as the test result in millimeters of induration (including 0 mm, if appropriate). Reporting results only as negative or positive is not satisfactory.

Effects on Driving

                
שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

SANOFI ISRAEL LTD

רישום

140 77 23830 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

06.01.22 - עלון לרופא 14.06.24 - עלון לרופא

עלון מידע לצרכן

10.11.20 - החמרה לעלון 10.11.20 - החמרה לעלון 06.01.22 - החמרה לעלון

לתרופה במאגר משרד הבריאות

טוברסול

קישורים נוספים

RxList WebMD Drugs.com